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Abstract
Introduction: The use of different facial cosmetic fillers has increased in recent years. The introduction of appa-
rently inert substances in the epidermis can give rise to foreign body granulomatous reactions.
Objetives: A literature review is made of the foreign body granulomatous reactions to cosmetic fillers.
Material and methods: A PubMed-Medline search was made using the following keywords: “granulomatous reac-
tions”, “foreign body reactions”, “esthetic fillers”, “cosmetic fillers”. The search was limited to articles published 
in English and Spanish during the last 10 years. A total of 22 articles were reviewed.
Results: A great variety of substances have been found to give rise to foreign body granulomatous reactions. The 
most common locations are the upper and lower lip and the nasogenian sulcus. The clinical presentation is variable 
and can range from single or multiple nodules to diffuse facial swelling of hard-elastic consistency, accompanied 
by reddening. Most lesions are asymptomatic or cause only mild discomfort. The literature describes different 
treatments, including systemic corticosteroids, local tacrolimus infiltrations, minocycline, retinoids, allopurinol, 
5% imiquimod, and surgical removal.
Conclusions: In view of the current demand for esthetic treatments, the use of cosmetic fillers can be expected to 
increase in future, together with the incidence of complications.
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Introduction
The use of different facial cosmetic fillers has increased 
in recent years (1-8). However, the introduction of appa-
rently inert substances in the epidermis can give rise 
to foreign body granulomatous reactions, among other 
undesirable effects (1, 2, 5). This has led to the develo-
pment of many new filler materials. However, despite 
the incorporated improvements, which have contributed 
to reduce the number of complications, no ideal product 
has been developed to date. Such an ideal product should 
be biocompatible (i.e., with a low foreign body reaction 
risk), easy to inject, non-allergenic, inert and unable to 
migrate or displace after injection (1, 9-12).
Different filler classifications have been proposed, ac-
cording to the origin, durability and biodegradability 
of the product. In this context, filler materials can be 
classified as reabsorbable (i.e., those in which tissue 
volume expansion after injection lasts a maximum of 
4-6 months), semi-permanent (lasting about 18 months) 
or permanent (i.e., materials that cannot be eliminated)
(3,4,7-9,11-13). Table 1 describes the materials that are 
currently available and their classification according to 
the durability of the filling effect.
Objectives
The present study offers a literature review of the foreign 
body granulomatous reactions to cosmetic fillers.
Material and methods
A PubMed-Medline literature search was made using 
the following keywords: “granulomatous reactions”, 
“foreign body reactions”, “esthetic fillers”, “cosmetic 
fillers”.
The search was limited to articles published in English 
and Spanish during the last 10 years.
A total of 22 articles were reviewed: one cross-sectional 
study, a cohort study, 9 clinical case series, 9 clinical 
cases and two review articles.
Results
A great variety of substances have been found to give 
rise to foreign body granulomatous reactions. The most 
popular include: silicone, collagen, hyaluronic acid ei-
ther alone or with acrylic gel (Dermalive®), polymethyl-
methacrylate (Artecoll®, Arteplast®), polylactic acid, 
hydroxyapatite and polyalkylamide (Bio-Alcamid®). 
The most common locations are the upper and lower lip 
and the nasogenian sulcus. The clinical presentation is 
variable and can range from single or multiple nodules 
to diffuse facial swelling of hard-elastic consistency, ac-
companied by reddening. Most lesions are asymptomatic 
or cause only mild discomfort. The literature describes 
different treatments, including systemic corticosteroids 
(prednisone), local tacrolimus infiltrations, minocycline, 
retinoids (isotretinoin), allopurinol, 5% imiquimod, and 
surgical removal.
Discussion
Independently of the filler material used, the mechanism 
of action and purpose are similar in all cases. The injec-
ted product induces a reaction of the surrounding con-
nective tissue, with the depositing of more or less stable 
collagen that persists independently of phagocytosis of 
the filler material. The underlying mechanism of action 
remains unclear, though infection has been suggested to 
trigger an immune cross-reaction, or alternatively dela-
yed immunity may be induced. In all cases, the objective 
of the filler material is to expand soft tissue volume.
Foreign body granulomatous reactions develop after 
a variable period of time ranging from 5 months to 15 
years (2). Sanchis-Bielsa et al. (1) reported an average 
time to reaction of 7.1 years. In the series published by 
Lombardi et al. (8), the mean time to symptoms onset 
was 1.5 years, while Ficarra et al. (10) recorded a mean 
of 4.5 years. Other studies have described longer latency 
periods of 4 or 5 years.
Adverse reactions have been reported with practically 
all the products used. Silicone was the first product em-
NON-PERMANENT SEMI-PERMANENT PERMANENT
Material Commercial 
brand examples
Material Commercial 
brand examples
Material Commercial brand 
examples
Collagen Zyderm®, 
Zyplast®
Polylactic acid  New-Fill® Silicone Bioplastique®,
Silikon® 
Hyaluronic acid 
derivatives
Restylane®,
Perlane®,
Hyaloform®
Calcium 
hydroxyapatite
 Radiesse® Hydroxy-ethyl-methacrylate Dermalive®
Dextran  Reviderm® Polymethylmethacrylate  Artecoll®,
Arteplast®
Hydroxypolyvinyl Evolution®
Polyacrylamide Aquamid®, 
Bio-Formacryl®
Polyalkylamide Bio-Alcamid®
Table 1. Filler materials are currently available and their classification according to the durability of the filling effect.
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ployed on a large scale, and therefore accounts for most 
of the reported undesirable effects and the most virulent 
reactions. The term “siliconoma” has been used in refe-
rence to the orofacial granulomatous reactions produced 
by silicone infiltration.
Systemic toxicity has been suggested with some of these 
filler products, particularly silicone, since deposits of the 
material have been found in liver, spleen and kidneys 
after subcutaneous injection. However, no relation to 
connective tissue diseases or other disorders has been 
established.
Local toxicity includes pain, edema, ecchymosis, erythe-
ma, color changes, alterations in skin texture, overco-
rrection effects and local embolic phenomena. There 
have also been descriptions of extensive ulcerations that 
can affect bone, muscle and nerve structures (14).
The clinical manifestations include swelling or tumefac-
tion of normally hard consistency. There have also been 
reports of reddening, burning sensation, tenderness in 
response to palpation and mild inflammation or even fi-
brous reactions. Sanchis-Bielsa et al. (1) found most pa-
tients to be asymptomatic – the reason for consultation 
being the presence of subcutaneous nodules, inflamma-
tion and deformation. They recorded no serious conse-
quences in their patients, though there were cases of im-
portant facial deformity, epidermal necrosis or extensive 
deformation after subcutaneous silicone infiltration.
The histological findings are characteristic, with giant 
multinucleated cells reflecting foreign body reactions. 
Silicone infiltrations usually show abundant macropha-
ges with intracytoplasmic vacuoles (15). Other products 
in turn induce classical foreign body granulomas in 
which fibrotic phenomena are also observed, along with 
violet-colored material deposits, asteroid bodies and his-
tiocyte infiltrates (16).
The differential diagnosis should include erysipela, 
allergic contact dermatitis, facial edema with eosino-
philia, apostematous glandularis cheilitis, Ascher syn-
drome, orofacial granulomatosis, Melkersson-Rosenthal 
syndrome, sarcoidosis, cutaneous leishmaniasis, leprosy 
or tuberculosis. Cases manifesting as well defined lip 
nodules are suggestive of salivary gland tumors or cysts, 
such as mucoceles, as well as soft tissue tumors and 
cysts (2, 10, 12).
Etiological treatment (i.e., removal of the injected mate-
rial) poses difficulties. Symptomatic treatment has inclu-
ded local and systemic corticosteroids (prednisolone 1 
mg/kg/day during 4-6 weeks, followed by gradual dose 
reduction). Corticosteroid injections inhibit fibroblast 
activity and the depositing of collagen, macrophage ac-
tivity and the formation of giant cells – avoiding pain 
and swelling in most cases. However, corticosteroids 
can produce surrounding skin atrophy secondary to the 
inhibition of fibroblasts and keratinocyte activity. The-
se side effects are dose-dependent, and skin atrophy in 
many cases is unavoidable (17).
Minocycline has yielded favorable results as a result of 
its antiinflammatory and immune modulating properties 
and anti-granulomatous effects, as demonstrated in vi-
tro.
Allopurinol has also been used in the treatment of sar-
coidosis and granulomas related to the use of cosmetic 
filler materials. In turn, while broad-spectrum antibiotic 
use has been reported, its efficacy has been questioned 
(12, 18, 19).
Other treatment proposals include 5% imiquimod (2, 20) 
and hyaluronidase in the case of granulomas secondary 
to hyaluronic acid infiltrations (21, 22).
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